FLUPHENAZINE HYDROCHLORIDE vs THIORIDAZINE HYDROCHLORIDE

Compare FLUPHENAZINE HYDROCHLORIDE (Fluphenazine Hydrochloride) and THIORIDAZINE HYDROCHLORIDE (Thioridazine Hydrochloride) — clinical data, side effects, and patient experiences.

FLUPHENAZINE HYDROCHLORIDE

Fluphenazine Hydrochloride · Typical Antipsychotic

How it works

Other agent

Approved for

See full prescribing information

OralTablet

THIORIDAZINE HYDROCHLORIDE

Thioridazine Hydrochloride · Typical Antipsychotic

How it works

Other agent

Approved for

potentially life threatening

proarrhythmic effects with thioridazine treatment

thioridazine hydrochloride tablets should be used only in patients who have failed to respond adequately to treatment with appropriate courses of other antipsychotic drugs

either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs. Consequently

OralTablet

Quick Comparison

FLUPHENAZINE HYDROCHLORIDETHIORIDAZINE HYDROCHLORIDE

Drug Class

Typical Antipsychotic

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

FLUPHENAZINE HYDROCHLORIDE

Drug Not Working

>10%

Weight Gain

1-10%

Anxiety

0.1-1%

Constipation

0.1-1%

THIORIDAZINE HYDROCHLORIDE

Weight Gain

1-10%

Drug Not Working

1-10%

Shortness of Breath

1-10%

General Unwellness

1-10%

Itching

1-10%

Ringing in Ears

1-10%

Abdominal Pain

1-10%

FDA Warnings

FLUPHENAZINE HYDROCHLORIDE

Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death
Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1
7 times the risk of death in placebo-treated patients
Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4

THIORIDAZINE HYDROCHLORIDE

WARNING Thioridazine has been shown to prolong the QTc interval in a dose related manner, and drugs with this potential, including thioridazine, have been associated with Torsades de pointes type arrhythmias and sudden death
Due to its potential for significant, possibly life threatening, proarrhythmic effects, thioridazine should be reserved for use in the treatment of schizophrenic patients who fail to show an acceptable response to adequate courses of treatment with other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs (see WARNINGS , CONTRAINDICATIONS , and INDICATIONS )
Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death
Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1

Clinical Trial Data

No head-to-head clinical studies found for FLUPHENAZINE HYDROCHLORIDE vs THIORIDAZINE HYDROCHLORIDE.

FLUPHENAZINE HYDROCHLORIDE vs THIORIDAZINE HYDROCHLORIDE: What You Should Know

Key Differences

Both FLUPHENAZINE HYDROCHLORIDE and THIORIDAZINE HYDROCHLORIDE belong to the Typical Antipsychotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

FLUPHENAZINE HYDROCHLORIDE carries 4 FDA warnings. THIORIDAZINE HYDROCHLORIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

FLUPHENAZINE HYDROCHLORIDE vs HALOPERIDOL→HALOPERIDOL vs THIORIDAZINE HYDROCHLORIDE→FLUPHENAZINE DECANOATE vs FLUPHENAZINE HYDROCHLORIDE→CHLORPROMAZINE vs FLUPHENAZINE HYDROCHLORIDE→FLUPHENAZINE HYDROCHLORIDE vs THIOTHIXENE→FLUPHENAZINE HYDROCHLORIDE vs PERPHENAZINE→

Loading comparison data...

FLUPHENAZINE HYDROCHLORIDE vs THIORIDAZINE HYDROCHLORIDE

Compare FLUPHENAZINE HYDROCHLORIDE (Fluphenazine Hydrochloride) and THIORIDAZINE HYDROCHLORIDE (Thioridazine Hydrochloride) — clinical data, side effects, and patient experiences.

FLUPHENAZINE HYDROCHLORIDE

Fluphenazine Hydrochloride · Typical Antipsychotic

How it works

Other agent

Approved for

See full prescribing information

OralTablet

THIORIDAZINE HYDROCHLORIDE

Thioridazine Hydrochloride · Typical Antipsychotic

How it works

Other agent

Approved for

potentially life threatening

proarrhythmic effects with thioridazine treatment

thioridazine hydrochloride tablets should be used only in patients who have failed to respond adequately to treatment with appropriate courses of other antipsychotic drugs

either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs. Consequently

OralTablet

Quick Comparison

FLUPHENAZINE HYDROCHLORIDETHIORIDAZINE HYDROCHLORIDE

Drug Class

Typical Antipsychotic

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

FLUPHENAZINE HYDROCHLORIDE

Drug Not Working

>10%

Weight Gain

1-10%

Anxiety

0.1-1%

Constipation

0.1-1%

THIORIDAZINE HYDROCHLORIDE

Weight Gain

1-10%

Drug Not Working

1-10%

Shortness of Breath

1-10%

General Unwellness

1-10%

Itching

1-10%

Ringing in Ears

1-10%

Abdominal Pain

1-10%

FDA Warnings

FLUPHENAZINE HYDROCHLORIDE

Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death
Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1
7 times the risk of death in placebo-treated patients
Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4

THIORIDAZINE HYDROCHLORIDE

WARNING Thioridazine has been shown to prolong the QTc interval in a dose related manner, and drugs with this potential, including thioridazine, have been associated with Torsades de pointes type arrhythmias and sudden death
Due to its potential for significant, possibly life threatening, proarrhythmic effects, thioridazine should be reserved for use in the treatment of schizophrenic patients who fail to show an acceptable response to adequate courses of treatment with other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs (see WARNINGS , CONTRAINDICATIONS , and INDICATIONS )
Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death
Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1

Clinical Trial Data

No head-to-head clinical studies found for FLUPHENAZINE HYDROCHLORIDE vs THIORIDAZINE HYDROCHLORIDE.

FLUPHENAZINE HYDROCHLORIDE vs THIORIDAZINE HYDROCHLORIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.